Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2015

Mar 19, 2015

65058_rns_2015-03-19_a8999e84-16d2-4173-8b93-93d23396d11a.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01 Amended 01/01/11
Name of entity PRIMARY HEALTH CARE LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

the director for the purposes of section 205G of the Corporations Act.
Name of Director Dr Edmund Gregory Thomas Bateman
Date of last notice 13 March 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Name of Director Name of Director Dr Edmund Gregory Thomas Bateman Dr Edmund Gregory Thomas Bateman
Date of last notice 13 March 2015
Part 1 - Change of di
rector’s relevant interests in securities
In the case of a trust, this iNote: In the case of a companybe disclosed in this part.Direct or indirect in ncludes interests in the trust made available by the responsible entity of the trust, interests which come within paragraph (i) of the definition of “notifiable interest of a director” shoul
Direct or indirect in terest As shown
Nature of indirect i(including registereNote: Provide details of the cirise to the relevant interest. nterestd holder)rcumstances giving As shown
Date of change 17 March 2015
No. of securities hechange ld prior to 506,483Abtourk (Syd No.391) Pty Ltd11,688,251Idameneo (No. 122) Pty Ltd Belinda Carwardine Bateman and
Class Fully paid ordinary shares
Number acquired Not applicable
Number disposed 500,000
Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation 500,000 at $5.10 per share
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after No. of securities held after No. of securities held after No. of securities held after
change 506,483 Abtourk (Syd No.391) Pty Ltd
11,188,251 Idameneo (No. 122) Pty Ltd
Belinda Carwardine Bateman and
104,836 Edmund Gregory Thomas Bateman
180,000 Belinda Carwardine Bateman
756,258 Dr Edmund Bateman
12,735,828 Ordinary shares
Nature of change
Example: on-market trade, off-market trade, On-market trade
exercise of options, issue of securities under
dividend reinvestment plan, participation in buy-
back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest Not applicable
Name of registered holder Not applicable
(if issued securities)
Date of change Not applicable
No. and class of securities to Not applicable
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired Not applicable
Interest disposed Not applicable
Value/Consideration Not applicable
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts Not applicable detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the Not applicable trade to proceed during this period? If prior written clearance was provided, on what date Not applicable was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011